Opendata, web and dolomites
H2020 projects about "bactericidal"
The page lists 15 projects related to the topic "bactericidal".
| # | |||
|---|---|---|---|
| 1 | IgEPath | IgEPath - Contributions of IgE-antibodies and IgE effector cells to host defense against pathogenic bacteria | 2015 |
| 2 | PROTOCOL | New processing technology for colistmethate sodium, leading to improved and cost-effective formulations for pharmaceutical and veterinary markets | 2015 |
| 3 | SVNanoVax | Structural Vaccinology in the design of bionanoparticles with multi-copy antigen display for vaccines with enhanced efficacy | 2015 |
| 4 | SEPCELL | Title of Proposal: Restoring the immune system homeostasis and organ function in severe community acquired pneumonia- induced sepsis through adipose derived allogeneic stem cells (SEPCELL Proje | 2015 |
| 5 | PYANO | Retargeted Pyocins: A novel tool for combating major food borne pathogens and exploitingphage-host interactions | 2016 |
| 6 | SWEETBULLETS | Sweet Theranostics in Bitter Infections - Seek and Destroy | 2017 |
| 7 | PeptIn | employing protein aggregation as an antibacterial design strategy | 2017 |
| 8 | POLYTHEA | Design and photo-optimization of Photosensitizer for Human Health and Food security applications or “how light can save lives” | 2018 |
| 9 | vAMRes | Vaccines as a remedy for antimicrobial resistant bacterial infections | 2018 |
| 10 | PHARMS | Bacteriophage inhibition of antibiotic-resistant pathogenic microbes and founding for novel therapeutic strategies | 2019 |
| 11 | SEPSCAV | SCAVENGING ON SEPSIS. DEVELOPMENT OF SEPSIS SPECIFIC DRUGS FROM HUMAN SCAVENGER RECEPTORS | 2019 |
| 12 | EpIg Men | The Role of Antibodies (Ig) and the Respiratory Epithelium in the Prevention of Invasive Meningococcal Infections in Different Age Groups | 2019 |
| 13 | PePiPOM | Peptide-functionalized POMs as biofilm disruption agents: searching for synergy in bactericidal materials | 2019 |
| 14 | Vacc-iNTS | Advancing a GMMA-based vaccine against invasive non-typhoidal salmonellosis through Phase 1 trial in Europe and sub-Saharan Africa | 2019 |
| 15 | ERA4TB | EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS | 2020 |